APA (7th ed.) Citation

SH, K., AL, C., CW, L., CH, H., MS, W., KH, Y., . . . LT, C. (2011). t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement. Cancer Chemotherapy & Pharmacology, 68(6), 1387.

Chicago Style (17th ed.) Citation

SH, Kuo, Cheng AL, Lin CW, Hsu CH, Wu MS, Yeh KH, Tzeng YS, and Chen LT. "T(11;18)(q21;q21) Translocation as Predictive Marker for Non-responsiveness to Salvage Thalidomide Therapy in Patients with Marginal Zone B-cell Lymphoma with Gastric Involvement." Cancer Chemotherapy & Pharmacology 68, no. 6 (2011): 1387.

MLA (9th ed.) Citation

SH, Kuo, et al. "T(11;18)(q21;q21) Translocation as Predictive Marker for Non-responsiveness to Salvage Thalidomide Therapy in Patients with Marginal Zone B-cell Lymphoma with Gastric Involvement." Cancer Chemotherapy & Pharmacology, vol. 68, no. 6, 2011, p. 1387.